Provided by Tiger Trade Technology Pte. Ltd.

Avis Budget

120.42
+5.815.06%
Post-market: 120.420.00000.00%17:42 EST
Volume:569.32K
Turnover:67.93M
Market Cap:4.24B
PE:-2.02
High:121.09
Open:114.44
Low:114.44
Close:114.62
52wk High:212.81
52wk Low:54.03
Shares:35.20M
Float Shares:14.77M
Volume Ratio:1.12
T/O Rate:3.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-59.6591
EPS(LYR):-51.2958
ROE:5800.00%
ROA:1.69%
PB:-1.77
PE(LYR):-2.35

Loading ...

Arovella reshapes board as CAR-iNKT cell therapy program advances

TIPRANKS
·
23 mins ago

Update: CAR Group Posts Higher Fiscal H1 Adjusted Earnings, Revenue; Reaffirms Fiscal 2026 Outlook; Shares Jump 11%

MT Newswires Live
·
1 hour ago

ASX Preview: Australian Shares Set to Rise Amid US Fed Policy Optimism; CAR Group Posts Higher Fiscal H1 Adjusted Earnings, Revenue

MT Newswires Live
·
1 hour ago

CAR Bull Likes Group's Boring 1H Result -- Market Talk

Dow Jones
·
1 hour ago

Citi Remains a Buy on CAR Group (WN6)

TIPRANKS
·
2 hours ago

CAR Group Releases Half-Year Update and Clarifies Use of Non-IFRS Metrics

TIPRANKS
·
3 hours ago

CAR Group posts strong H1 FY26 result as AI and global platforms drive growth

TIPRANKS
·
3 hours ago

CAR Group declares interim dividend of AUD 0.425 per share

TIPRANKS
·
3 hours ago

CAR Group lifts half-year profit and raises interim dividend amid ongoing expansion

TIPRANKS
·
3 hours ago

CAR Group Posts Fiscal H1 Adjusted EPS of AU$0.52 Vs FactSet Estimate of AU$0.52, Revenue of AU$625.8 Million Vs FactSet Estimate of AU$619 Million

MT Newswires Live
·
3 hours ago

Arovella Wins FDA IND Clearance as It Enters Clinical Stage With CAR-iNKT Cancer Therapy

TIPRANKS
·
Feb 05

Tempest Announces Closing of Strategic Acquisition of Dual-Targeting CAR-T Assets

GlobeNewswire
·
Feb 05

AdAlta outlines ‘East to West’ strategy to expand CAR-T access across Australia and SE Asia

TIPRANKS
·
Feb 04

Carbon credit demand plateaued in 2025 as buyers sorted by quality, compliance and durability

Fastmarkets
·
Feb 03

These 10 Stocks Could Be Short Squeeze Targets: Lucid, Kohl's, Avis and More

Benzinga_recent_news
·
Feb 03

ASX Dividend Stocks To Consider In February 2026

Simply Wall St.
·
Feb 02

Imugene Posts Strong Azer-cel Data and Cuts Costs as It Advances Toward Pivotal Trial

TIPRANKS
·
Jan 30

CAR Group (WN6) Receives a Buy from Morgans

TIPRANKS
·
Jan 30

Immix Biopharma Receives U.S. FDA Breakthrough Therapy Designation for NXC-201

GlobeNewswire
·
Jan 28

BioNTech Announces Appointment of Kylie Jimenez to Management Board as Chief People Officer

GlobeNewswire
·
Jan 28